Filing Details

Accession Number:
0001225208-14-024552
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-12-09 10:44:59
Reporting Period:
2014-12-08
Filing Date:
2014-12-09
Accepted Time:
2014-12-09 10:44:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
78003 Pfizer Inc PFE Pharmaceutical Preparations (2834) 135315170
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1566333 J Anthony Maddaluna Pfizer Inc.-Corp. Secretary
235 East 42Nd St.
New York NY 10017
Executive Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2014-12-08 6,500 $32.00 82,830 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 49,470 Indirect By Rule 16b-3 Plan